← Back to Patent Explorer
US4410634A Expired / Lapsed US ⏱️ 0.0 years remaining

Method of passively adsorbing immuno-reactive haptens to solid phases

Assignee: Whittaker Bioproducts Inc
•
Filing: 1981-11-12
•
Granted: 1983-10-18
•
Expires: 2001-11-12
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract The method comprises covalently binding an immuno-reactive to a selected macromolecular carrier and then contacting the resulting hapten-carrier conjugate at a selected concentration in a liquid phase with a selected solid phase until a desired amount of the hapten-carrier conjugate is adsorbed to the surface of the solid phase. Unbound hapten-carrier conjugate is then separated from the solid phase, and the solid phase containing the bound hapten-carrier conjugate is recovered for use in quantitative immunoassays and the like. The solid phase can be, for example, surfaces of a test tube or microtiter well or the like. The method is simple and inexpensive and permits hapten assays of improved sensitivity.

Inventors

  • 👤 Harold R. Cooper
  • 👤 Andrew O'Beirne

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-28 20:50
CPC Classifications
G; G01; G01N; G01N33/00; G01N33/48; G01N33/50; G01N33/53; G01N33/543; G01N33/544; G01N33/545; G01N33/74; G01N33/78; Y; Y10; Y10S; Y10S435/00; Y10S435/961; Y10S435/966; Y10S436/00; Y10S436/804; Y10S436/815; Y10S436/823

Claims Analysis

Total Claims: 8
Claim 1
Independent Claim 147 words
A method of readily adsorbing immuno-reactive hapten to a solid phase for an immuno-assay, which hapten otherwise would not readily adsorb to said solid phase and retain its immuno-reactivity, which method retains said immuno-reactivity and comprises: a. covalently binding an immuno-reactive hapten selected from the group consisting of digoxin, thyroxin, gentamicin, and triiodothyronine to a macromolecular carrier selected from the group consisting of bovine serum albumin, and human serum albumin through the use of a coupled agent selected from the group consisting of glutaraldehyde, and periodate with sodium borohydride; b. contacting the resulting hapten-carrier conjugate with a solid phase selected from the group consisting of polystyrene, and polyvinyl acetate until a desired concentration of said hapten-carrier conjugate is adsorbed to the surface of said solid phase; and, c. thereafter removing unbound hapten-carrier conjugate from said solid phase and recovering said solid phase containing said bound hapten-carrier conjugate.
Claim 2
Independent Claim 147 words
A method of readily adsorbing immuno-reactive hapten to a solid phase for an immuno-assay, which hapten otherwise would not readily adsorb to said solid phase and retain its immuno-reactivity, which method retains said immuno-reactivity and comprises: a. covalently binding an immuno-reactive hapten selected from the group consisting of digoxin, thyroxin, gentamicin, and triiodothyronine to a macromolecular carrier selected from the group consisting of bovine serum albumin, and human serum albumin through the use of a coupled agent selected from the group consisting of glutaraldehyde, and periodate with sodium borohydride; b. contacting the resulting hapten-carrier conjugate with a solid phase selected from the group consisting of polystyrene, and polyvinyl acetate until a desired concentration of said hapten-carrier conjugate is adsorbed to the surface of said solid phase; and, c. thereafter removing unbound hapten-carrier conjugate from said solid phase and recovering said solid phase containing said bound hapten-carrier conjugate.
Claim 3
Dependent Claim 23 words
The method of claim 1 wherein said hapten-carrier conjugate is in a liquid phase when said contacting with said solid phase is initiated.
Claim 4
Dependent Claim 31 words
The method of claim 2 wherein said hapten-carrier conjugate is diluted to a desired concentration with a liquid diluent and then contacted with said solid phase while still in said diluent.
Claim 5
Dependent Claim 34 words
The method of claim 1 wherein said hapten comprises digoxin, wherein said macromolecular carrier comprises human serum albumin, wherein said coupling reagent comprises periodate and sodium borohydride, and wherein said solid phase comprises polystyrene.
Claim 6
Dependent Claim 31 words
The method of claim 1 wherein said hapten comprises thyroxin, wherein said macromolecular carrier comprises bovine serum albumin, wherein said coupling reagent comprises glutaraldehyde, and wherein said solid phase comprises polystyrene.
Claim 7
Dependent Claim 31 words
The method of claim 1 wherein said hapten comprises gentamicin, wherein said macromolecular carrier comprises bovine serum albumin, wherein said coupling reagent comprises glutaraldehyde, and wherein said solid phase comprises polystyrene.
Claim 8
Dependent Claim 33 words
The method of claim 1 wherein said hapten comprises triiodothyronine, wherein said macromolecular carrier comprises bovine serum albumin, wherein said coupling reagent comprises gluta aldehyde, and wherein said solid phase comprises polyvinyl acetate.

References Cited (Backward Citations)

US3940475A Cited
US3879262A Cited
US4092116A Cited
US4001583A Cited
US4017597A Cited
US3951748A Cited
US4036823A Cited
US4053459A Cited
US4100268A Cited
US4104026A Cited
US4070246A Cited
US4069352A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1986-10-17 1987-04-18 1987-10-18 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1990-10-17 1991-04-18 1991-10-18 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1994-10-17 1995-04-18 1995-10-18 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag